Tenpoint Therapeutics

Vision Restoration for Presbyopia, Cataracts, and Geographic Atrophy | Tenpoint Therapeutics™

Irvine, United States · Founded 2019 · $155.0M raised

Headquarters
Irvine, California
Employees
51–200
Founded
2019
Business Model
B2B
Total Funding
$155.0M
Last Round
$85.0M Series BJan 2026
Rounds
2

About

Tenpoint Therapeutics is a global clinical-stage biotech company developing regenerative medicines to restore vision in aging eyes. Its pipeline targets presbyopia, cataracts, and geographic atrophy, with lead candidate YUVEZZI for age-related lens conditions. The company was founded in 2019 and operates across the United States and United Kingdom.

Summary

Tenpoint Therapeutics is a Biotech company based in Irvine, United States, founded in 2019. It has raised $155.0M in total across 2 rounds, most recently a $85.0M Series B round in Jan 2026. Investors include F-Prime Capital and Sofinnova Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2026
$85.0M

Sign up to see all 3 rounds

Series A through Credit Line — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tenpoint Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/tenpoint-therapeutics"><img src="https://indexed.vc/api/badge/company/tenpoint-therapeutics" alt="Tenpoint Therapeutics on Indexed.vc" width="260" height="76" /></a>